BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 38472593)

  • 1. Accuracy of screening mammography in women with a history of lobular carcinoma in situ or atypical hyperplasia of the breast.
    Houssami N; Abraham LA; Onega T; Collins LC; Sprague BL; Hill DA; Miglioretti DL
    Breast Cancer Res Treat; 2014 Jun; 145(3):765-73. PubMed ID: 24800915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upgrade Rates of Pure, Radiology-Pathology Concordant Lobular Neoplasia Diagnosed on Breast Core Needle Biopsy: Is Surgical Excision Warranted?
    Karimi Z; Phillips J; Brook A; Baker G; Guzman Y; Mehta TS
    Acad Radiol; 2022 Jul; 29(7):1029-1038. PubMed ID: 34702673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literature.
    Foschini MP; Miglio R; Fiore R; Baldovini C; Castellano I; Callagy G; Bianchi S; Kaya H; Amendoeira I; Querzoli P; Poli F; Scatena C; Cordoba A; Pietribiasi F; Kovács A; Faistova H; Cserni G; Quinn C
    Eur J Surg Oncol; 2019 Dec; 45(12):2279-2286. PubMed ID: 31301938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive lobular neoplasia of the breast: Morphologic features, clinical presentation, and management dilemmas.
    Calle C; Kuba MG; Brogi E
    Breast J; 2020 Jun; 26(6):1148-1155. PubMed ID: 32500575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate and delayed risk of breast cancer associated with classic lobular carcinoma in situ and its variants.
    Chung HL; Middleton LP; Sun J; Whitman GJ
    Breast Cancer Res Treat; 2024 Jun; 205(3):545-554. PubMed ID: 38472593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ.
    Nakhlis F; Harrison BT; Giess CS; Lester SC; Hughes KS; Coopey SB; King TA
    Ann Surg Oncol; 2019 Jan; 26(1):55-61. PubMed ID: 30362065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upgrade Rates of Variant Lobular Carcinoma In Situ Compared to Classic Lobular Carcinoma In Situ Diagnosed in Core Needle Biopsies: A 10-Year Single Institution Retrospective Study.
    Harinath L; Villatoro TM; Clark BZ; Fine JL; Yu J; Carter GJ; Diego E; McAuliffe PF; Mai P; Lu A; Zuley M; Berg WA; Bhargava R
    Mod Pathol; 2024 Apr; 37(4):100462. PubMed ID: 38428736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Outcomes of Lobular Neoplasia Diagnosed in Core Biopsy: Prospective Study of 316 Cases.
    Susnik B; Day D; Abeln E; Bowman T; Krueger J; Swenson KK; Tsai ML; Bretzke ML; Lillemoe TJ
    Clin Breast Cancer; 2016 Dec; 16(6):507-513. PubMed ID: 27425222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.
    Elsheikh TM; Silverman JF
    Am J Surg Pathol; 2005 Apr; 29(4):534-43. PubMed ID: 15767810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up.
    Mahoney MC; Robinson-Smith TM; Shaughnessy EA
    AJR Am J Roentgenol; 2006 Oct; 187(4):949-54. PubMed ID: 16985141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lobular Carcinoma In Situ during Preoperative Biopsy and the Rate of Upgrade.
    Lee J; Ku GY; Lee H; Park HS; Ku JS; Kim JY; Park S; Park BW
    Cancer Res Treat; 2022 Oct; 54(4):1074-1080. PubMed ID: 34942684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypia in breast pathology: what pathologists need to know.
    Katayama A; Toss MS; Parkin M; Ellis IO; Quinn C; Rakha EA
    Pathology; 2022 Feb; 54(1):20-31. PubMed ID: 34872753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Outcomes for Classic-Type Lobular Carcinoma In Situ Managed with Surgical Excision After Core Biopsy Versus Observation.
    Matar R; Sevilimedu V; Park A; King TA; Pilewskie M
    Ann Surg Oncol; 2022 Mar; 29(3):1670-1679. PubMed ID: 34671879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobular neoplasia detected at MRI-guided biopsy: imaging findings and outcomes.
    Chikarmane SA; Harrison BT; Giess CS; Pinkney DM; Gombos EC
    Clin Imaging; 2021 Oct; 78():171-178. PubMed ID: 33838434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision.
    Kuba MG; Murray MP; Coffey K; Calle C; Morrow M; Brogi E
    Mod Pathol; 2021 Aug; 34(8):1495-1506. PubMed ID: 33824462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lobular intraepithelial neoplasia: Outcomes and optimal management.
    Boland PA; Dunne EC; Kovanaite A; Stokes M; Kell MR; Barry JM; Kennedy M; Flanagan F; Walsh SM
    Breast J; 2020 Dec; 26(12):2383-2390. PubMed ID: 33270304
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.